Capricor Therapeutics reported $3.38M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Bioline Rx BLRX:US $ 3.71M 0.94M
Bluebird Bio BLUE:US $ 0M 0M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Cytokinetics CYTK:US $ 197.98M 55.14M
Cytori Therapeutics CYTX:US $ 6.33M 0.29M
Geron GERN:US $ 50.18M 0.35M
Johnson & Johnson JNJ:US $ 33148M 603M
Newlink Genetics NLNK:US $ 0M 0M
Prothena PRTA:US $ 0M 0M
Ptc Therapeutics PTCT:US $ 1197.09M 8.62M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Vascular Biogenics VBLT:US 0 0
Vital Therapies VTL:US $ 0M 0M